Windlas Biotech Ltd (WINDLAS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003519,
    "name": "Windlas Biotech",
    "stock_name": "Windlas Biotech",
    "full_name": "Windlas Biotech Ltd",
    "name_url": "stocks-analysis/windlas-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "856.30",
    "chg": 19.4,
    "chgp": "2.32%",
    "dir": 1,
    "prev_price": "836.90",
    "mcapval": "1,752.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543329,
    "symbol": "WINDLAS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0H5O01029",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "90.66 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/windlas-biotech-1003519-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Windlas Biotech Ltd Faces Mixed Technical Signals Amid Mildly Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-faces-mixed-technical-signals-amid-mildly-bearish-momentum-3823705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WindlasBiotechL_technicaldot_3823705.png",
        "date": "2026-02-06 08:03:33",
        "description": "Windlas Biotech Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflecting a complex interplay of market forces that investors should carefully consider."
      },
      {
        "title": "Windlas Biotech Q3 FY26: Steady Growth Marred by Margin Pressure and Weak Profitability",
        "link": "https://www.marketsmojo.com/news/result-analysis/windlas-biotech-q3-fy26-steady-growth-marred-by-margin-pressure-and-weak-profitability-3823330",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WindlasBiotech_quaterlyResult_3823330.png",
        "date": "2026-02-05 20:05:25",
        "description": "Windlas Biotech Ltd., a small-cap pharmaceutical contract development and manufacturing organisation (CDMO), reported mixed results for Q3 FY26 (October-December 2025), with net sales continuing their upward trajectory but profitability showing minimal sequential improvement. The company posted net profit of ₹17.80 crores for the quarter, representing a modest 0.79% quarter-on-quarter growth but a respectable 13.67% year-on-year increase. With a market capitalisation of ₹1,741 crores, the stock has faced significant headwinds, declining 17.27% over the past year and currently trading at ₹843.00, down 25.90% from its 52-week high of ₹1,137.60."
      },
      {
        "title": "Windlas Biotech Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-upgraded-to-hold-as-technicals-improve-amid-mixed-financial-signals-3821895",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WindlasBiotechL_mojoScore_3821895.png",
        "date": "2026-02-05 08:28:59",
        "description": "Windlas Biotech Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable shift in its technical outlook and financial performance. The company’s improved technical indicators, steady financial trends, and fair valuation underpin this revised stance, despite some lingering concerns over long-term growth and recent underperformance relative to the broader market."
      },
      {
        "title": "Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-3821766",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WindlasBiotechL_technicaldot_3821766.png",
        "date": "2026-02-05 08:05:04",
        "description": "Windlas Biotech Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, signalling a potential consolidation phase. Recent technical indicators present a mixed picture, with weekly charts showing mild bullishness while monthly signals remain cautiously bearish. This nuanced technical landscape warrants close attention from investors seeking to gauge the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Windlas Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-ltd-is-rated-sell-3816138",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WindlasBiotechL_mojoScore_3816138.png",
        "date": "2026-02-02 10:10:47",
        "description": "Windlas Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 November 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3808808",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WindlasBiotechL_technicaldot_3808808.png",
        "date": "2026-01-29 08:03:14",
        "description": "Windlas Biotech Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from a Hold to a Sell rating by MarketsMOJO, the stock’s price action and key technical indicators suggest a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Windlas Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-faces-bearish-momentum-amid-technical-downgrade-3805010",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WindlasBiotechL_technicaldot_3805010.png",
        "date": "2026-01-27 08:03:20",
        "description": "Windlas Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests increasing caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Windlas Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-ltd-is-rated-sell-3799827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WindlasBiotechL_mojoScore_3799827.png",
        "date": "2026-01-22 10:10:58",
        "description": "Windlas Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Windlas Biotech Ltd Hits Intraday High with 7.03% Surge on 14 Jan 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-hits-intraday-high-with-703-surge-on-14-jan-2026-3792211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WindlasBiotechL_priceRelatedfactors_3792211.png",
        "date": "2026-01-14 15:46:19",
        "description": "Windlas Biotech Ltd recorded a robust intraday performance on 14 Jan 2026, surging 7.03% to touch a day’s high of Rs 867, significantly outperforming the Pharmaceuticals & Biotechnology sector and broader market indices."
      }
    ],
    "total": 253,
    "sid": "1003519",
    "stock_news_url": "https://www.marketsmojo.com/news/windlas-biotech-1003519"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "29-Jan-2026",
      "details": "Schedule of Conference Call to discuss financial performance for the quarter and nine months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Thursday February 5 2026",
      "datetime": "28-Jan-2026",
      "details": "Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve To inter alia consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-Jan-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Windlas Biotech Ltd has declared <strong>116%</strong> dividend, ex-date: 21 Jul 25",
          "dt": "2025-07-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Windlas Biotech Ltd Faces Mixed Technical Signals Amid Mildly Bearish Momentum

2026-02-06 08:03:33

Windlas Biotech Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflecting a complex interplay of market forces that investors should carefully consider.

Read full news article

Windlas Biotech Q3 FY26: Steady Growth Marred by Margin Pressure and Weak Profitability

2026-02-05 20:05:25

Windlas Biotech Ltd., a small-cap pharmaceutical contract development and manufacturing organisation (CDMO), reported mixed results for Q3 FY26 (October-December 2025), with net sales continuing their upward trajectory but profitability showing minimal sequential improvement. The company posted net profit of ₹17.80 crores for the quarter, representing a modest 0.79% quarter-on-quarter growth but a respectable 13.67% year-on-year increase. With a market capitalisation of ₹1,741 crores, the stock has faced significant headwinds, declining 17.27% over the past year and currently trading at ₹843.00, down 25.90% from its 52-week high of ₹1,137.60.

Read full news article

Windlas Biotech Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals

2026-02-05 08:28:59

Windlas Biotech Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable shift in its technical outlook and financial performance. The company’s improved technical indicators, steady financial trends, and fair valuation underpin this revised stance, despite some lingering concerns over long-term growth and recent underperformance relative to the broader market.

Read full news article

Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-05 08:05:04

Windlas Biotech Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, signalling a potential consolidation phase. Recent technical indicators present a mixed picture, with weekly charts showing mild bullishness while monthly signals remain cautiously bearish. This nuanced technical landscape warrants close attention from investors seeking to gauge the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Read full news article

Windlas Biotech Ltd is Rated Sell

2026-02-02 10:10:47

Windlas Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 November 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-29 08:03:14

Windlas Biotech Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from a Hold to a Sell rating by MarketsMOJO, the stock’s price action and key technical indicators suggest a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Windlas Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-01-27 08:03:20

Windlas Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests increasing caution for investors amid a challenging market backdrop.

Read full news article

Windlas Biotech Ltd is Rated Sell

2026-01-22 10:10:58

Windlas Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Windlas Biotech Ltd Hits Intraday High with 7.03% Surge on 14 Jan 2026

2026-01-14 15:46:19

Windlas Biotech Ltd recorded a robust intraday performance on 14 Jan 2026, surging 7.03% to touch a day’s high of Rs 867, significantly outperforming the Pharmaceuticals & Biotechnology sector and broader market indices.

Read full news article

View All News